Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

Rockx, Barry, Kuiken, Thijs, Herfst, Sander, Bestebroer, Theo, Lamers, Mart M., Oude Munnink, Bas B., de Meulder, Dennis, van Amerongen, Geert +16 more·2020·Science
DOI 10.1126/science.abb7314

Cited by (878)

Items 601–700 of 878

  1. Covid-19 Pneumonia: Do Not leave the Corticosteroids Behind!
    Simone Mornese Pinna, Silvia Scabini, Silvia Corcione, Tommaso Lupia, Francesco Giuseppe De Rosa · 2021 · Future Microbiology
  2. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view
    Sujan Chatterjee, Snehasis Mishra, Kaustav Dutta Chowdhury, Chandan Kumar Ghosh, Krishna Das Saha · 2021 · Life Sciences
  3. Airway models in a pandemic: Suitability of models in modeling SARS-CoV-2
    Andrew Teo, Caroline Lin Lin Chua, Louisa Chan · 2022 · PLoS Pathogens
  4. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
    Xiaohui Wei, Na Rong, Jiangning Liu · 2022 · Frontiers in Immunology
  5. Eliminating Potential Effects of Other Infections During Selection of Nonhuman Primates for COVID-19 Research
    Márcia Cristina Ribeiro Andrade, Bárbara Regina Pickler Lemos, Larissa Moura da Silva, Jerilyn K. Pecotte · 2023 · Comparative Medicine
  6. Utilizing non‐human primate models to combat recent COVID ‐19/ SARS‐CoV ‐2 and viral infectious disease outbreaks
    Taeho Kwon · 2023 · Journal of Medical Primatology
  7. INCIDENCE OF RIFAMPICIN-RESISTANCE PRESUMPTIVE M. TUBERCULOSIS CASES AMONG OUTPATIENTS IN KEBBI STATE, NIGERIA
    Mohammed Bashar Danlami, Basiru Aliyu, G. E. Rupert Samuel · 2020 · African Journal of Infectious Diseases
  8. Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies
    D. Focosi, F. Maggi, M. Franchini, A. Aguzzi, M. Lanza, A. Mazzoni, F. Menichetti · 2021 · Clinical Microbiology and Infection
  9. Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques
    Patrick Madden, M. S. Arif, Mark E. Becker, Michael D. McRaven, A. M. Carias, R. Lorenzo-Redondo, Si-Xia Xiao, C. Midkiff, R. Blair, E. L. Potter et al. · 2021 · Frontiers in Immunology
  10. Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis
    Chaobao Zhang, Hongzhi Wang, Zilu Wen, Mingjun Gu, Lianyong Liu, Xiangqi Li · 2022 · Frontiers in Cellular and Infection Microbiology
  11. Animal Models for COVID-19 Therapeutic Development: Where We Are and Where We Need to Go
    Sihai Zhao, Jianglin Fan, Enqi Liu · 2022 · Frontiers in Microbiology
  12. Cell tropism and viral clearance during SARS-CoV-2 lung infection
    Constantin Schwab, Lisa Maria Domke, Fabian Rose, Ingrid Haußer, Peter Schirmacher, Thomas Longerich · 2022 · Pathology - Research and Practice
  13. COVID-19 and the Cardiovascular System: How the First PostModern Pandemic ‘Weakened’ our Hearts
    Syeda Tasneem Towhid, Nadira Naznin Rakhi, ASM Shamsul Arefin, Otun Saha, Sumaiya Mamun, Mohammad Moniruzzaman, Md. Mizanur Rahaman · 2020 · Discoveries Reports
  14. COVID-19: A Veterinary and One Health Perspective
    Deepak Kumar, J. Bayry, N. Hegde · 2022 · Journal of the Indian Institute of Science
  15. Understanding the cell biology of SARS-CoV-2 endocytosis for COVID-19 drug repurposing: looking beyond chloroquine
    Oleg O. Glebov · 2020
  16. Promising role of Vitamin D and plant metabolites against COVID-19: Clinical trials review
    Rupanshee Srivastava, Nidhi Singh, Tripti Kanda, Sadhana Yadav, Shivam Yadav, Piyush Choudhary, Neelam Atri · 2023 · Heliyon
  17. Shared genetics and causal association between plasma levels of SARS ‐ CoV ‐2 entry receptor ACE2 and Alzheimer's disease
    Yan Zhang, Fang Xu, Tao Wang, Zhifa Han, Hong Shang, Kevin Han, Ping Zhu, Shan Gao, Xiaojie Wang, Yanli Xue et al. · 2024 · CNS Neuroscience & Therapeutics
  18. Female squirrel monkeys as models for research on women’s pelvic floor disorders
    Gessiane Pereira da Silva, Thyago Habner de Souza Pereira, Ana Kelen Felipe Lima, W. R. R. Vicente, Thomas J. Kuehl, Julio Cesar Ruiz, Frederico Ozanan Barros Monteiro · 2021 · Laboratory Animals
  19. SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model
    Yunyun Di, Jocelyne M. Lew, Una Goncin, Anna Radomska, Saurav Saswat Rout, Bridget E. T. Gray, Steven Machtaler, Darryl Falzarano, Kerry J. Lavender · 2022 · Viruses
  20. Primate Tourism
    Malene Friis Hansen, Stefano Kaburu, Kristen S. Morrow, Laëtitia Maréchal · 2023 · Developments in primatology
  21. Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1
    Albert D. M. E. Osterhaus, Mariana González-Hernández, Franziska Kaiser, Imke Steffen, Małgorzata Ciurkiewicz, G van Amerongen, Ronen Tchelet, Mark Emalfarb, Markku Saloheimo, Marilyn G. Wiebe et al. · 2023 · Frontiers in Immunology
  22. Neuromuscular defects after infection with a beta coronavirus in mice
    Leonardo Rossi, Ana F. Almeida‐Santos, Barbara I.S. Mota, Jordane Clarisse Pimenta, Bruna Oliveira, Caroline Amaral Machado, Heliana de Barros Fernandes, Leticia A. Barbosa, Hermann Alecsandro Rodrigues, Gabriel H.M. Teixeira et al. · 2023 · Neurochemistry International
  23. Pathogenesis of severe acute respiratory syndrome coronavirus-2 in nonhuman primates.
    Taylor Saturday, N. van Doremalen · 2023 · Current Opinion in Virology
  24. Loss of Smell in COVID-19 Patients: New Biomarkers
    Kemal Koray Bal, Sedat Alagöz, Talih Özdaş, Nur Yücel Ekici, Gökhan Kuran, Orhan Görgülü · 2021 · Indian Journal of Otolaryngology and Head & Neck Surgery
  25. Emerging Landscape of Preclinical Models for Studying COVID-19 Neurologic Diseases
    Jason Li, Jing Wang, Hu Wang · 2023 · ACS Pharmacology & Translational Science
  26. Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
    Ahmed M. Awad, Kamryn Hansen, Diana Del Rio, Derek Flores, Reham F. Barghash, Laura Kakkola, Ilkka Julkunen, Kareem Awad · 2023 · Biomolecules
  27. COVID-19 and animals: What do we know?
    Serkan Gönültaş, Murat KARABAĞLI, Yavuz Baştuğ, Nusret Can Çilesiz, Ateş Kadıoğlu · 2020 · Urology Research and Practice
  28. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges
    Idris Nasir Abdullahi, Anthony Uchenna Emeribe, Hafeez Aderinsayo Adekola, Sharafudeen Dahiru Abubakar, Amos Dangana, Halima Ali Shuwa, Sunday Theophilus Nwoba, Jelili Olaide Mustapha, Muyideen Haruna, Adepeju Kafayat Olowookere et al. · 2020 · Human Vaccines & Immunotherapeutics
  29. SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications
    Francesca SANGUEDOLCE, Magda ZANELLI, Stefano ASCANI, Maurizio Zizzo, Simona TORTORELLA, Alessandra SORIANO, Alberto CAVAZZA, Francesco SOLLITTO, Domenico LOIZZI · 2021 · Panminerva Medica
  30. SARS, SARS again, and MERS. Review of animal models of human respiratory syndromes caused by coronavirus infections
    Нагорных Алексей Михайлович, Alexander I. Tyumentsev, Marina A. Tyumentseva, В. Г. Акимкин · 2020 · Journal of microbiology epidemiology immunobiology
  31. An overview of preclinical animal models for SARS-CoV-2 pathogenicity
    Itti Munshi, Aditya Khandvilkar, Shrinivas Chavan, G. Sachdeva, S. Mahale, U. Chaudhari · 2021 · The Indian journal of medical research
  32. A Meta-Analysis of Rhesus Macaques (Macaca mulatta), Cynomolgus Macaques (Macaca fascicularis), African green monkeys (Chlorocebus aethiops), and Ferrets (Mustela putorius furo) as Large Animal Models for COVID-19.
    Alexandra N. Witt, Rachel D Green, A. Winterborn · 2021 · Comparative medicine
  33. Molecular mechanisms and signaling pathways involved in immunopathological events of COVID-19
    Ali Asghar Peyvandi, Somayeh Niknazar, Fatemeh Zare Mehrjerdi, Hojjat‐Allah Abbaszadeh, Shahrokh Khoshsirat, Maryam Peyvandi · 2021 · Physiology and Pharmacology
  34. An Update on Animal Models for Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Countermeasure Development
    Liang Zhang, Shuai-Yin Chen, Wei-Guo Zhang, Hai-Yan Yang, Yuefei Jin, Guang-Cai Duan · 2021 · Frontiers in Microbiology
  35. Animal Models of COVID-19: Nonhuman Primates
    Dhiraj Kumar Singh, Journey Cole, Ruby A. Escobedo, Kendra J. Alfson, Bindu Singh, Tae‐Hyung Lee, Xavier A. Alvarez, Shashank Ganatra, Ricardo Carrion, Deepak Kaushal · 2022 · Methods in molecular biology
  36. SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication
    Hashim Ali, Asma Naseem, Zaheenul Islam Siddiqui · 2023 · Journal of Clinical Medicine
  37. The future of sepsis research: time to think differently?
    Julie A. Bastarache · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  38. The peripheral T cell population is associated with pneumonia severity in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus 2
    Noriyo Nagata, Naoko Iwata‐Yoshikawa, Kaori Sano, Akira Ainai, Nozomi Shiwa, Masayuki Shirakura, Noriko Kishida, Tomoko Arita, Yasushi A. Suzuki, Toshihiko Harada et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  39. The BioNTech / Pfizer vaccine BNT162b2 induces class-switched SARS-CoV-2-specific plasma cells and potential memory B cells as well as IgG and IgA serum and IgG saliva antibodies upon the first immunization
    Anne Sophie Lixenfeld, Inga Künsting, Emily Martin, Vera von Kopylow, Selina Lehrian, Hanna B. Lunding, Jana Sophia Buhre, Janna Quack, Moritz Steinhaus, Tobias Graf et al. · 2021 · medRxiv
  40. SARS-CoV-2 infection of olfactory epithelial cells and neurons drives acute lung injury and lethal COVID-19 in mice
    Alan T. Tang, David W. Buchholz, Katherine M. Szigety, Brian Imbhiaka, Siqi Gao, Maxwell Frankfurter, Min Wang, Jisheng Yang, Peter Hewins, Patricia Mericko-Ishizuka et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Early circulating strain of SARS-CoV-2 causes severe pneumonia distinct from that caused by variants of concern
    Yusuke Matsumoto, Fumihiko Yasui, Akinori Endo, Takahiro Sanada, Tsubasa Munakata, Asako Takagi, Kenzaburo Yamaji, Naoki Yamamoto, Yasushi Saeki, Michinori Kohara · 2022 · Research Square
  42. Male sex and age biases viral burden, viral shedding, and type 1 and 2 interferon responses during SARS-CoV-2 infection in ferrets
    Magen Ellen Francis, Brian Richardson, Mara McNeil, Melissa L. Rioux, Mary K. Foley, Anni Ge, Roger D. Pechous, Jason Kindrachuk, Cheryl Cameron, Christopher Richardson et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection
    Zhuo Long Zhou, Xinyi Zhang, Xiaobo Lei, Xiao Xia, Tao Jiao, Ruiyi Ma, Xiaojing Dong, Qi Jiang, Wenjing Wang, Yujin Shi et al. · 2021
  44. Administration of airborne pathogens in non-human primates
    Justina Creppy, Benoît Delache, Julien Lemaître, Branka Horvat, Laurent Vecellio, Frédéric Ducancel · 2024 · Inhalation Toxicology
  45. Ex vivo functional whole organ in biomedical research: a review
    Karthikeyan Subbiahanadar Chelladurai, Jackson Durairaj Selvan Christyraj, Kamarajan Rajagopalan, Kayalvizhi Vadivelu, Meikandan Chandrasekar, Puja Das, Kalimuthu Kalishwaralal, Nivedha Balamurugan, Vijayalakshmi Subramanian, Johnson Retnaraj Samuel Selvan Christyraj · 2024 · Journal of Artificial Organs
  46. The Impact of PET Imaging on Translational Medicine: Insights from Large-Animal Disease Models
    Zhengyan Deng, Peng Xi, Dongye Zheng, Zhaoheng Xie, Xiangxi Meng, Qiushi Ren · 2025 · Biomolecules
  47. Astroglia-mediated neuroinflammation as a putative mechanism of neurological outcomes in COVID-19? Insights from a Brazilian cohort
    Ethiane Segabinazi, Fernando Ribeiro Tocantins, Talita Glaser, Tamires Gomes Maglio, N.C. Oliveira, Andrelissa Gorete Castanha, Fabiele Baldino Russo, Paulo Emílio Corrêa Leite, Anita Brito, Camila Vieira Molina et al. · 2025 · Brain Behavior & Immunity - Health
  48. The First Days and Months of the COVID-19 Pandemic
    Ilyes Zatla, Lamia Boublenza, Hafida Hassaïne · 2022 · Research & Reviews A Journal of Microbiology and Virology
  49. Characterization of a Vesicular Stomatitis Virus-Vectored Recombinant Virus Bearing Spike Protein of SARS-CoV-2 Delta Variant
    Wenwen He, Huan Cui, Shen Wang, Bo Liang, Cheng Zhang, Weiqi Wang, Qi Wang, Wu-Jian Li, Yong-Kun Zhao, Tie-Cheng Wang et al. · 2023 · Microorganisms
  50. The Development of Lung Tissue Engineering: From Biomaterials to Multicellular Systems
    Jingge Ma, Chengtie Wu, Jin‐Fu Xu · 2024 · Advanced Healthcare Materials
  51. Bison, Elk, and Other Captive Wildlife Species Humoral Immune Responses against SARS-CoV-2
    Mehrnaz Ardalan, Konner R. Cool, Natasha N. Gaudreault, Dashzeveg Bold, Catherine Rojas, Anna Mannix, Janine F. R. Seetahal, Jüergen A. Richt, Roman M. Pogranichniy · 2024 · Animals
  52. A detailed examination of coronavirus disease 2019 (COVID-19): Covering past and future perspectives
    Sabina Yasmin, Mohammad Yousuf Ansari · 2025 · Microbial Pathogenesis
  53. Analysis of COVID-19 spreading and prevention strategy in schools based on continuous infection model
    Hao-Chen Sun, Xiao Fan Liu, Xiao-Ke Xu, Ye Wu · 2020 · Acta Physica Sinica
  54. A REVIEW ON THE FIFTH PANDEMIC: CORONAVIRUS
    Navdeep Kaur, KAUR SIMRANPREET, KAUR MANJINDER · 2020 · Asian Journal of Pharmaceutical and Clinical Research
  55. One Year of the COVID‐19 Pandemic. What Do We Know and What Is Yet to Come? — The Summarising Review
    Wojciech Malchrzak, Agnieszka Mastalerz–Migas, Zbigniew Sroka, Maciej Spiegel · 2021 · International Journal of Public Health
  56. Interspecies Comparisons of the Effects of Potential Antiviral 3-Amidinophenylalanine Derivatives on Cytochrome P450 1A2 Isoenzyme
    Zsófia Fedor, Anna Szentkirályi-Tóth, G. Nagy, Zoltán Szimrók, Eszter Varga, Anna Pászti, Z. Pászti, Á. Jerzsele, O. Pilgram, T. Steinmetzer et al. · 2022 · Veterinary Sciences
  57. A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination
    Fabien Abdul, Pascale Ribaux, Aurélie Caillon, Astrid Malézieux-Picard, Virginie Prendki, Nathalie Vernaz, Nikolay Zhukovsky, Flavien Delhaes, Karl‐Heinz Krause, Olivier Preynat‐Seauve · 2022 · Viruses
  58. An Outlook on Dental Practices to Avoid the Oral Transmission of COVID-19
    Manal Alsulami, Waad Kattan, Lama Alsamadani, Ghadah Alahmari, Wasan Al Juhani, Maha Almabadi · 2023 · Microorganisms
  59. A functional nanoflower based lateral flow immunoassay for the rapid and robust detection of pathogens
    Yucheng Liu, Wang Wang, Xuesong Feng, Xinghu Ji, Zhike He · 2023 · The Analyst
  60. Microfluidics: From Evolution and Applications to Potential Prospects and Challenges
    Mohammad Irfan Hajam, Mohammad Mohsin Khan · 2023 · Advances in mechatronics and mechanical engineering (AMME) book series
  61. In Vivo Models for Evaluation of Drug Efficacy: Demand and Challenges
    Somya Asthana, Vibha Shukla, Anurag Tripathi · 2023 · Springer eBooks
  62. Analysis of SARS-CoV-2 Mutations after Nirmatrelvir Treatment in a Lung Cancer Xenograft Mouse Model
    BoKyu Kang, Dongbum Kim, Jinsoo Kim, Kyeongbin Baek, Sangkyu Park, Ha-Eun Shin, Myeong-Heon Lee, Minyoung Kim, Suyeon Kim, Younghee Lee et al. · 2024 · Biomolecules & Therapeutics
  63. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2): A Perspective Through the Lens of the Veterinary Diagnostic Laboratory
    T. Stokol, D. McAloose, K. Terio, F. Salguero · 2020 · Frontiers in Veterinary Science
  64. The possible role of immunoglobulin A monoclonal antibodies against COVID-19 infection
    RaghdahMaytham Hameed, MohanadKadhim Mirdan Al-Ibraheemi, Falah Hasan Obayes Al-Khikani, NoorFlayyih Hasan, HudaAli Salman Almosawey, AtyafAli Al-Asadi · 2020 · Matrix Science Medica
  65. Olfactory function and findings on chest computed tomography in COVID-19: is there any correlation?
    Lucas Resende Lucinda Mangia, Marcelly Botelho Soares, Thiago Sasso Carmona de Souza, Patrícia Cristina Scarabotto, Roberta David João De Masi, Gabriel Lucca de Oliveira Salvador, Rogério de Azevedo Hamerschmidt · 2020 · Acta Oto-Laryngologica
  66. Olfactory Dysfunction: A Clinical Marker of COVID-19
    Apar Pokharel · 2021 · Journal of Nepal Medical Association
  67. Correlation Between Anosmia and Severity Along with Requirement of Tocilizumab in COVID-19 Patients
    Manju Silu, Navneet Prasad Mathur, Rekha Kumari, Pallavi Chaudhary · 2021 · Indian Journal of Otolaryngology and Head & Neck Surgery
  68. In-vitro and In-vivo Experimental Models for MERS-CoV, SARSCoV, and SARS-CoV-2 Viral Infection: A Compendious Review
    Sonia Kaur Singh, Aman Kumar, Himanshu Sharma · 2022 · Recent Patents on Biotechnology
  69. Testing for SARS-CoV-2 Infection in Care Home Residents and Staff in English Care Homes: A Service Evaluation
    Emma Smith, Clare F Aldus, Julii Suzanne Brainard, Sharon Dunham, Paul Raymond Hunter, Nicholas Steel, Paul Everden · 2022 · Journal of Long-Term Care
  70. Intrinsic host susceptibility among multiple species to intranasal SARS-CoV-2 identifies diverse virological, biodistribution and pathological outcomes
    N. Berry, D. Ferguson, S. Kempster, Jo Hall, C. Ham, A. Jenkins, Vicky Rannow, Elaine Giles, Rose Leahy, Sara Goulding et al. · 2022 · Scientific Reports
  71. The Isolation and In Vitro Differentiation of Primary Fetal Baboon Tracheal Epithelial Cells for the Study of SARS-CoV-2 Host-Virus Interactions
    Subramaniyan Bharathiraja, Sunam Gurung, Manish Bodas, Andrew R. Moore, Jason L. Larabee, Darlene N. Reuter, Constantin Georgescu, Jonathan D. Wren, Dean A. Myers, James F. Papin et al. · 2023 · Viruses
  72. Neutralizing Antibodies against the SARS-CoV-2 Ancestral Strain and Omicron BA.1 Subvariant in Dogs and Cats in Mexico
    Freddy Dehesa-Canseco, Pastrana-Unzueta Roxana, Nadia Carrillo-Guzmán, Francisco Liljehult-Fuentes, Juan Diego Pérez-de la Rosa, Humberto Ramírez‐Mendoza, José Guillermo Estrada-Franco, Roberto Navarro‐López, Jesús Hernández, Mario Solís-Hernández · 2023 · Pathogens
  73. Protection against Severe Illness versus Immunity—Redefining Vaccine Effectiveness in the Aftermath of COVID-19
    Renuka Roche, Nouha Odeh, Abhay U. Andar, Mohan E. Tulapurkar, Joseph A. Roche · 2023 · Microorganisms
  74. Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques
    Bryce M. Warner, Mable Chan, Nikesh Tailor, Robert Vendramelli, Jonathan Audet, Courtney Erin Meilleur, Thang Truong, Lauren Garnett, Marnie Willman, Geoff Soule et al. · 2024 · Vaccines
  75. Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey
    Estefanía Calvo Alvarez, Maria Dolci, Federica Perego, Lucia Signorini, Silvia Parapini, Sarah D’Alessandro, Luca Denti, Nicoletta Basilico, Donatella Taramelli, Pasquale Ferrante et al. · 2022 · Microorganisms
  76. COVID-19 basics and vaccine development with a Canadian perspective
    Marina Liu, Daniel Chen · 2020 · Canadian Journal of Microbiology
  77. Delta-range coupling between prefrontal cortex and hippocampus supported by respiratory rhythmic input from the olfactory bulb in freely behaving rats
    Rola Mofleh, Bernát Kocsis · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  78. COVID-19 in a case previously infected with MERS-CoV: No cross immunity
    Amal Saif Al-Maani, Amina Al‐Jardani, Hassan Karrar, Eskild Petersen, Seif Al Abri · 2020 · Journal of Infection
  79. Back Pain and Related Factors in Patients with COVID-19
    Cuma Uz, Ebru Umay, İbrahim Gündoğdu, Fatma Ballı Uz · 2020 · Research Square
  80. Comparison of SARS-CoV-2 Infections Among Three Species of Non-Human Primates
    Shuaiyao Lu, Yuan Zhao, Wenhai Yu, Yun Yang, Jiahong Gao, Junbin Wang, Dexuan Kuang, Mengli Yang, Jing Yang, Chunxia Ma et al. · 2020 · SSRN Electronic Journal
  81. Recombinant Fc-fusion vaccine of RBD induced protection against SARS-CoV-2 in non-human primate and mice
    Shihui Sun, Lei He, Zhongpeng Zhao, Hongjing Gu, Xin De Fang, Tiecheng Wang, Xiaolan Yang, Shaolong Chen, Yong‐Qiang Deng, Jiangfan Li et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Rise of Macaque Models for Immunity and Infection Research
    Arpan Acharya, Siddappa N. Byrareddy · 2024 · Springer eBooks
  83. Improving Learning of New Diseases Through Knowledge-Enhanced Initialization for Federated Adapter Tuning
    Danni Peng, Yuan Wang, Kangning Cai, Peiyan Ning, Jiming Xu, Yong Liu, Rick Siow Mong Goh, Qingsong Wei, Huazhu Fu · 2025 · IEEE Transactions on Medical Imaging
  84. Approach for the study of COVID-19 infection and vaccine development using mice model: A narrative review
    Lismayana Hansur, Melva Louisa, Puspita Eka Wuyung · 2022 · AIP conference proceedings
  85. Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals
    Carla Usai, Lola Pailler‐García, Cristina Lorca-Oró, Leira Fernández‐Bastit, Núria Roca, Marco Brustolin, Jordi Rodon, Mónica Pérez, Guillermo Cantero, Jorge Carrillo et al. · 2022 · Frontiers in Microbiology
  86. Spanish Flu and Covid-19: Historical Correlations and Bioethical Implications
    Cristina Tornali, Flavio Vecchio, Ignazio Vecchio · 2020 · Journal of Clinical Research & Bioethics
  87. Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation
    Masuko Katoh, Masaru Katoh · 2021 · Frontiers in Molecular Medicine
  88. The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients
    Sunanda Biswas Mukherjee, Rajesh Detroja, Sumit Mukherjee, Milana Frenkel‐Morgenstern · 2023 · Viruses
  89. The role of receptors in the cross-species spread of coronaviruses infecting humans and pigs
    Jie Zhuang, Zhiwei Yan, Tiezhong Zhou, Yonggang Li, Huinuan Wang · 2024 · Archives of Virology
  90. Animal Models for Long COVID: Current Advances, Limitations, and Future Directions
    Yu Zhang, Huan Chen, Yumeng Li, Chenxi Luo, Yunkai Zhu, Xiaoyang Zhou, Ruixuan Wang, Jiuxiang He, Hongxia Guo, Xiao-Feng Xu et al. · 2025 · Journal of Medical Virology
  91. Pulmonary lymphoid tissue induced after SARS-CoV-2 infection in rhesus macaques
    Zhong-Min Ma, Katherine J. Olstad, Koen K. A. Van Rompay, Smita Swaminathan Iyer, Christopher Miller, J. Rachel Reader · 2025 · Frontiers in Immunology
  92. Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: Analysis of 944 patients in Apulia, Italy
    Moris Sangineto, Fabio Arena, Rosella De Nittis, Rosanna Villani, Crescenzio Gallo, Gaetano Serviddio · 2021 · International Journal of Infectious Diseases
  93. Are We Paving the Way to Dig Out of the “Pandemic Hole”? A Narrative Review on SARS-CoV-2 Vaccination: From Animal Models to Human Immunization
    Giuseppe Tardiolo, Pina Brianti, Daniela Sapienza, Pia dell’Utri, Viviane Di Dio, Giuseppe Rao, Rocco Salvatore Calabrò · 2021 · Medical Sciences
  94. Transcriptome Analysis of Lungs in a Mouse Model of Severe COVID-19
    Inbar Cohen-Gihon, Ofir Israeli, Avital Tidhar, Anita Sapoznikov, Yentl Evgy, Dana Stein, Moshe Aftalion, David Gur, Irit Orr, Anat Zvi et al. · 2022 · Frontiers in Virology
  95. Heterogeneous influence of individuals’ behavior on mask efficacy in gathering environments
    Hao-Chen Sun, Xiao Fan Liu, Zhanwei Du, Ye Wu, Haifeng Zhang, Xiao-Ke Xu · 2022 · Frontiers of Engineering Management
  96. Biochemistry-informed design selects potent siRNAs against SARS-CoV-2
    Élisabeth Houbron, Sophie Mockly, Sophia Rafasse, Nathalie Gros, Delphine M. Muriaux, Hervé Seitz · 2023 · RNA Biology
  97. Covid-19, prise en charge, pistes thérapeutiques et vaccinales
    Élodie Matusik, Mériam Ayadi, Nicolas Picard · 2020 · Actualités Pharmaceutiques
  98. Synthetic Lung Surfactant Treatment for COVID-19 Pneumonia
    Frans J. Walther, Alan J. Waring · 2020 · Coronaviruses
  99. Laboratory information management system for COVID-19 non-clinical efficacy trial data
    Suhyeon Yoon, Hyuna Noh, Heejin Jin, Sungyoung Lee, Soyul Han, Sunghee Kim, Jiseon Kim, Jung Seon Seo, Jeong Jin Kim, In Ho Park et al. · 2022 · Laboratory Animal Research
  100. Dam-infant rhesus macaque pairs to dissect age-dependent responses to SARS-CoV-2 infection
    S. Langel, C. Garrido, C. Phan, Tatianna Travieso, H. Kirshner, Todd Demarco, Zhong-Min Ma, J. Reader, K. Olstad, R. Sammak et al. · 2022 · ImmunoHorizons